Hyoscine Butylbromide Effect on Duration of Labor

Completed 218 enrolled Saint Thomas Hospital, Panama Sistema Nacional de Investigadores de Panamá · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the duration of labour (active phase of labour) in nulliparous women with gestations between 37 and 41 6/7 weeks when 20 mg of Hyoscine butylbromide was applied intravenously and compared with similar patients that received a placebo.

Timeline

Start: 2019-07-12
Primary completion: 2019-08-30
Completion: 2019-11-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hyoscine butylbromide	Unknown	20 mg	Intravenous

Indications

No indication recorded.